Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MegaNatural-Az grapeseed extract is a proprietary, standardized dietary supplement derived from the seeds of California grapes (Vitis vinifera). It is rich in polyphenolic compounds—primarily oligomeric proanthocyanidins—which are potent antioxidants. The product has been studied for its potential cardiovascular benefits (such as supporting healthy blood pressure and endothelial function) and cognitive health effects. Preclinical research suggests that it may inhibit the formation of complex amyloid structures in the brain, potentially offsetting cognitive decline associated with Alzheimer's disease by preventing amyloid aggregation[4][5]. Its primary mechanism involves antioxidant activity and modulation of oxidative stress pathways; it may also influence vascular relaxation through effects on nitric oxide signaling[3][9]. Developed using a patented water-based extraction process to ensure purity and high polyphenol content.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Meganatural-Az grapeseed extract.